So they used minimal doses on the SIRT arm and maximum dosages (compared to what payers will support on at least the number of months they will pay) on the sorafenib arm.
Not helpful to SRX and not real world use (not to also mention the 3 week additional delay in treatment compared to current practice).
Sirt result, page-78
Add SRX (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
17.5¢ |
Change
0.000(0.00%) |
Mkt cap ! $74.27M | |||
| Open | High | Low | Value | Volume |
| 17.5¢ | 17.5¢ | 17.5¢ | $1.602K | 9.154K |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 8 | 3847679 | 17.5¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 18.0¢ | 2509481 | 36 |
View Market Depth
| Last trade - 15.19pm 23/08/2024 (20 minute delay) ? |
| SRX (ASX) Chart |